Gabelli Funds LLC Has $2.33 Million Position in Nutrien Ltd. (NYSE:NTR)

Gabelli Funds LLC raised its stake in shares of Nutrien Ltd. (NYSE:NTR) by 33.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 52,090 shares of the company’s stock after purchasing an additional 13,000 shares during the period. Gabelli Funds LLC’s holdings in Nutrien were worth $2,331,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Uncommon Cents Investing LLC grew its stake in shares of Nutrien by 2.1% in the 4th quarter. Uncommon Cents Investing LLC now owns 11,550 shares of the company’s stock valued at $517,000 after purchasing an additional 235 shares during the period. Rhumbline Advisers boosted its stake in Nutrien by 3.5% in the 4th quarter. Rhumbline Advisers now owns 7,398 shares of the company’s stock valued at $331,000 after buying an additional 247 shares in the last quarter. FFT Wealth Management LLC grew its position in Nutrien by 0.9% in the fourth quarter. FFT Wealth Management LLC now owns 29,732 shares of the company’s stock valued at $1,330,000 after acquiring an additional 277 shares during the period. EverSource Wealth Advisors LLC raised its stake in Nutrien by 23.9% during the fourth quarter. EverSource Wealth Advisors LLC now owns 1,804 shares of the company’s stock worth $81,000 after acquiring an additional 348 shares in the last quarter. Finally, PFG Investments LLC lifted its holdings in shares of Nutrien by 2.0% during the fourth quarter. PFG Investments LLC now owns 20,097 shares of the company’s stock valued at $899,000 after acquiring an additional 386 shares during the period. Institutional investors own 63.10% of the company’s stock.

Nutrien Stock Down 1.4 %

Shares of NYSE NTR opened at $52.50 on Friday. Nutrien Ltd. has a 1 year low of $43.70 and a 1 year high of $60.87. The firm’s 50-day moving average is $50.86 and its 200-day moving average is $49.26. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $25.66 billion, a PE ratio of 38.32, a price-to-earnings-growth ratio of 1.19 and a beta of 0.77.

Nutrien (NYSE:NTR) last announced its quarterly earnings data on Wednesday, February 19th. The company reported $0.28 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.09). The business had revenue of $5.08 billion during the quarter, compared to the consensus estimate of $5.09 billion. Nutrien had a net margin of 2.62% and a return on equity of 6.81%. Equities analysts expect that Nutrien Ltd. will post 3.72 EPS for the current year.

Nutrien Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, April 10th. Shareholders of record on Monday, March 31st were issued a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 4.15%. The ex-dividend date was Monday, March 31st. Nutrien’s dividend payout ratio (DPR) is currently 159.12%.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on NTR. Barclays increased their target price on shares of Nutrien from $56.00 to $59.00 and gave the stock an “equal weight” rating in a research report on Wednesday, March 5th. Piper Sandler raised their price objective on shares of Nutrien from $58.00 to $63.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. The Goldman Sachs Group began coverage on Nutrien in a report on Thursday, March 13th. They issued a “sell” rating and a $53.00 target price on the stock. Berenberg Bank raised their price target on Nutrien from $54.00 to $59.00 and gave the company a “buy” rating in a report on Tuesday. Finally, BNP Paribas raised Nutrien to a “strong-buy” rating in a research note on Wednesday, April 9th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $59.40.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.